1. 236. Treatment of Recurrent Clostridioides difficile Infection With RBX2660 in Patients ≥ 65 Years Old With Underlying Comorbidities. (15th December 2022) Authors: Tillotson, Glenn S; Feuerstadt, Paul; Archbald-Pannone, Laurie; Archbald-Pannone, Laurie; Johnson, Stuart; Ng, Samson; Ando, Masakazu; Harvey, Adam Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Age‐Dependent Tolerability and Adenoma Detection With a Ready‐to‐Drink Low‐Volume Bowel Preparation: Subgroup Analysis From a Randomized, Assessor‐Blinded, Multicenter Study: 323. (October 2019) Authors: Bertiger, Gerald; Hookey, Lawrence; Johnson, Kenneth L.; Ando, Masakazu; Stong, Laura; Khan, Nadeem; Dahdal, David N. Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy, safety, and tolerability of a ready-to-drink bowel preparation in overweight and obese adults: subanalysis by body mass index from a phase III, assessor-blinded study. (April 2020) Authors: Hookey, Lawrence; Bertiger, Gerald; Johnson, Kenneth Lee; Boules, Mena; Ando, Masakazu; Dahdal, David N. Journal: Therapeutic advances in gastroenterology Issue: Volume 13(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy, safety, and tolerability of a ready-to-drink bowel preparation in overweight and obese adults: subanalysis by body mass index from a phase III, assessor-blinded study. (April 2020) Authors: Hookey, Lawrence; Bertiger, Gerald; Johnson, Kenneth Lee; Boules, Mena; Ando, Masakazu; Dahdal, David N. Journal: Therapeutic advances in gastroenterology Issue: Volume 13(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy, safety, and tolerability of a ready-to-drink bowel preparation: subanalysis by age from a phase III, assessor-blinded study. (February 2020) Authors: Hookey, Lawrence; Bertiger, Gerald; Johnson, Kenneth Lee; Boules, Mena; Ando, Masakazu; Dahdal, David N. Journal: Therapeutic advances in gastroenterology Issue: Volume 13(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy, safety, and tolerability of a ready-to-drink bowel preparation: subanalysis by age from a phase III, assessor-blinded study. (February 2020) Authors: Hookey, Lawrence; Bertiger, Gerald; Johnson, Kenneth Lee; Boules, Mena; Ando, Masakazu; Dahdal, David N. Journal: Therapeutic advances in gastroenterology Issue: Volume 13(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Microbiota-Based Live Biotherapeutic RBX2660 for the Reduction of Recurrent Clostridioides difficile Infection in Older Adults With Underlying Comorbidities. (30th December 2022) Authors: Tillotson, Glenn; Archbald-Pannone, Laurie; Johnson, Stuart; Ng, Samson; Ando, Masakazu; Harvey, Adam; Bancke, Lindy; Feuerstadt, Paul Journal: Open forum infectious diseases Issue: Volume 10:Number 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Polyp Detection and Histology by Colon Cleansing Quality With a Ready‐to‐Drink Low Volume Bowel Preparation: Subgroup Analysis From a Randomized, Assessor‐Blinded, Multicenter Study: 568. (October 2019) Authors: Bertiger, Gerald; Hookey, Lawrence; Johnson, Kenneth L.; Ando, Masakazu; Stong, Laura; Chacar, Christelle; Dahdal, David N. Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. S157 24-Month Sustained Clinical Response and Safety of RBX2660 in Participants With Recurrent Clostridioides difficile Infection: Subgroup Analysis. (October 2022) Authors: Lee, Christine; Hecht, Gail; Tillotson, Glenn; Harvey, Adam; Ng, Samson; Ando, Masakazu; LaPlante, Kerry; Dubberke, Erik R. Other Names: Orenstein Robert presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S159 Efficacy and Safety of RBX2660 in Reducing Recurrent Clostridioides difficile Infection in Patients With Underlying Gastrointestinal Comorbidities. (October 2022) Authors: Dubberke, Erik R.; Knapple, Whitfield L.; Feuerstadt, Paul; Assi, Maha; Ng, Samson; Guthmueller, Beth; Ando, Masakazu Other Names: Khanna Sahil presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗